Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using an selective serotonin reuptake inhibitor

Neurologist

Volumn 18, Issue 4, 2012, Pages 204-205

  Dardis, Christopher ^a   Omoregie, Eghosa ^a   Ly, Vanthanh ^b  

^a Downstate Health Sciences University   (United States)

^b NYHHCS   (United States)

Author keywords

carbamazepine; oxcarbazepine; serotonin reuptake inhibitor; serotonin syndrome; sertraline

Indexed keywords

ACETYLSALICYLIC ACID; AMIKACIN; ATENOLOL; CIPROFLOXACIN; CREATINE KINASE; FENTANYL; FUROSEMIDE; GABAPENTIN; GLIPIZIDE; HYDROCORTISONE; IPRATROPIUM BROMIDE; LEVOFLOXACIN; LINEZOLID; METRONIDAZOLE; MIDAZOLAM; NORADRENALIN; OXCARBAZEPINE; SALBUTAMOL SULFATE; SERTRALINE; VASOPRESSIN;

AGED; CASE REPORT; CELLULITIS; DEATH; DISEASE PREDISPOSITION; DRUG FATALITY; EXTUBATION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; INTUBATION; LEG PAIN; LETHARGY; LEUKOCYTOSIS; LONG TERM CARE; MALE; MEAN ARTERIAL PRESSURE; NEUROPATHIC PAIN; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; SEROTONIN SYNDROME; SKIN REDNESS; SWELLING; VOMITING;

AGED, 80 AND OVER; ANALGESICS; ANTIHYPERTENSIVE AGENTS; ATRIAL FIBRILLATION; BRONCHODILATOR AGENTS; CARBAMAZEPINE; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; DIABETIC NEUROPATHIES; DRUG INTERACTIONS; FATAL OUTCOME; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; MALE; NEURALGIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 84863563137     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e31825cf3f3     Document Type: Review

References (15)

1. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112-1120.
2. Radomski JW, Dursun SM, Reveley MA, et al. An exploratory approach to the serotonin syndrome: An update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses. 2000;55:218-224.
3. Grunze H, Kasper S, Goodwin G, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression. World J Biol Psychiatry. 2002;3:115-124.
4. Dursun SM, Mathew VM, Reveley MA. Toxic serotonin syndrome after fluoxetine plus carbamazepine. Lancet. 1993;342:442-443. (Pubitemid 23236381)
5. Bang LM, Goa KL. Spotlight on oxcarbazepine in epilepsy. CNS Drugs. 2004;18:57-61.
6. Kobayashi K, Ishizuka T, Shimada N, et al. Sertraline Ndemethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro. Drug Metab Dispos. 1999;27:763-766. (Pubitemid 29297771)
7. Rudorfer MV, Potter WZ. The role of metabolites of antidepressants in the treatment of depression. CNS Drugs. 1997;7:273-312. (Pubitemid 27195910)
8. Rudberg I, Hendset M, Uthus LH, et al. Heterozygous mutation in CYP2C19 significantly increases the concentration/dose ratio of racemic citalopram and escitalopram (S-citalopram). Ther Drug Monit. 2006;28:102-105. (Pubitemid 44391702)
9. Goldstein JA. Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br J Clin Pharmacol. 2001;52:349-355. (Pubitemid 32939439)
10. Kirchheiner J, Brosen K, Dahl ML, et al. CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: A first step towards subpopulation-specific dosages. Acta Psychiatr Scand. 2001;104:173-192. (Pubitemid 32762271)
11. Rasmussen BB, Brosen K. Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors? Ther Drug Monit. 2000;22:143-154. (Pubitemid 30196816)
12. Lundmark J, Reis M, Bengtsson F. Therapeutic drug monitoring of sertraline: Variability factors as displayed in a clinical setting. Ther Drug Monit. 2000;22:446-454. (Pubitemid 30622118)
13. Clinckers R, Smolders I, Meurs A, et al. Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine. Neurosci Lett. 2005;390:48-53. (Pubitemid 41317788)
14. Dailey JW, Reith ME, Steidley KR, et al. Carbamazepine-induced release of serotonin from rat hippocampus in vitro. Epilepsia. 1998;39:1054-1063. (Pubitemid 28458035)
15. Ener RA, Meglathery SB, Van DeckerWA, et al. Serotonin syndrome and other serotonergic disorders. Pain Med. 2003;4:63-74.